VIDAS ® B·R·A·H·M·S PCT™ (PCT) is an automated test for use on the VIDAS ® instruments for the determination of procalcitonin in human serum or plasma.
VIDAS® B·R·A·H·M·S PCT ™ - 30450-01
Device Description
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of procalcitonin (PCT) in a clinical specimen, using an enzyme immunoassay (EIA) method. It is typically used as a marker of bacterial sepsis or severe bacterial infection.
Environmental Conditions
- 8.00
- 2.00
Device Sizes
No Data Available
Device Sterilization
Device Sterile: False
Sterilization Prior To Use: False
Sterilization Methods: No Data Available
Product Codes
Code: NTM
Device Name: Antigen, Inflammatory Response Marker, Sepsis
Device Class: 2
Physical State: N/A
Definition: An immunoluminometric assay used to determine the concentration of procalcitonin (pct) in human serum and plasma.
Submission Type ID: 1
Review Panel: MI
Review Code: N/A
Technical Method: N
Gmp Exempt Flag: N/A
Life Sustain Support Flag: N
Unclassified Reason: N/A
Implant Flag: N
Target Area: N/A
Regulation Number: 866.3210
Third Party Flag: N
Medical Specialty: MI
Code: PMT
Device Name: Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens
Device Class: 2
Physical State: In vitro diagnostic device
Definition: An assay used to determine the level of procalcitonin (PCT) in human serum and plasma as an aid in assessing the mortality for patients diagnosed with severe sepsis or septic shock.
Submission Type ID: 1
Review Panel: MI
Review Code: N/A
Technical Method: N
Gmp Exempt Flag: Immunoassay, ELISA
Life Sustain Support Flag: N
Unclassified Reason: N/A
Implant Flag: N
Target Area: Detection and determination the concentration of PCT (procalcitonin) in human serum and EDTA or heparin plasma specimens.
Regulation Number: 866.3215
Third Party Flag: N
Medical Specialty: MI
Code: PRI
Device Name: Procalcitonin Assay
Device Class: 2
Physical State: In vitro diagnostic device
Definition: To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the Emergency Department, with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Submission Type ID: 1
Review Panel: MI
Review Code: N/A
Technical Method: N
Gmp Exempt Flag: Immunoassay, ELISA
Life Sustain Support Flag: N
Unclassified Reason: N/A
Implant Flag: N
Target Area: Human serum and EDTA or heparin plasma specimens.
Regulation Number: 866.3215
Third Party Flag: N
Medical Specialty: MI
Device IdentifiersDevice Id: 03573026223601
Device Type: Primary
DeviceId Issuing Agency: GS1
Contains DI Number: N/A
Package Quantity: N/A
Package Discontinue Date: N/A
Package Status: N/A
Package Type: N/A